GRAIL, Inc.
GRAL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001699031
In the last 90 days, GRAIL, Inc. insiders filed 0 open-market purchases and 8 sales; 379 institutions reported holding it in 13F filings for Q2 2026, worth $2.60B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 16, 2026
- $4.75B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $15.2M in total
- 8
- 13F holdersQ2 2026, +15 vs. previous quarter
- 379
- 13F valueReported value at the end of Q2 2026
- $2.60B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $147.2M
- +17.2% year over year
- Net income, FY2025
- -$408.4M
- No comparable prior period
- Free cash flow, FY2025
- -$299.9M
- No comparable prior period
- Revenue, Q3 FY2026
- $37.5M
- +3.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $408.4M (277.5% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 8.00M
- Shares sold short
- Change
- −176.0K
- −2.2% vs. previous
- Days to cover
- 8.70
- At average daily volume
Superinvestors holding GRAL, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding GRAL at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by GRAIL, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 (view filing)9:09 PM ET | Nov 16 | Same day | Freidin AaronChief Financial Officer | SSale | −3.00K | $107.62 | −$322.9K | −1.3%222.4K after | 6 lots10b5-1 |
| Oct 16, 2026 (view filing)4:50 PM ET | Oct 15 | 1 day | Ofman Joshua J.Chief Executive Officer | SSale | −20.0K | $136.85 | −$2.74M | −5.5%342.3K after | 6 lots10b5-1 |
| Oct 7, 2026 (view filing)6:36 PM ET | Oct 5 | 2 days | Partridge Andrew JohnChief Growth Officer | SSale | −7.87K | $146.39 | −$1.15M | −4.8%155.9K after | |
| Oct 7, 2026 (view filing)6:36 PM ET | Oct 5 | 2 days | Freidin AaronChief Financial Officer | SSale | −23.6K | $146.39 | −$3.46M | −9.5%225.4K after | |
| Sep 23, 2026 (view filing)4:37 PM ET | Sep 21 | 2 days | Freidin AaronChief Financial Officer | SSale | −4.10K | $93.34 | −$382.7K | −1.6%249.0K after | 3 lots10b5-1 |
| Sep 23, 2026 (view filing)4:37 PM ET | Sep 21 | 2 days | Ofman Joshua J.Chief Executive Officer | SSale | −61.5K | $97.74 | −$6.01M | −14.5%362.3K after | 8 lots10b5-1 |
| Aug 31, 2026 (view filing)8:07 PM ET | Aug 27 | 4 days | Ofman Joshua J.Chief Executive Officer | SSale | −5.00K | $85.02 | −$425.1K | −1.2%397.3K after | 10b5-1 |
| Aug 31, 2026 (view filing)8:07 PM ET | Aug 27 | 4 days | Freidin AaronChief Financial Officer | SSale | −7.90K | $85.01 | −$671.6K | −3.0%253.1K after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 4 | 1 day | Partridge Andrew JohnChief Growth Officer | SSale | −1.49K | $61.08 | −$91.1K | −0.9%163.7K after | |
| Apr 9, 2026 (view filing) | Apr 8 | 1 day | Freidin AaronChief Financial Officer | SSale | −45.8K | $49.92 | −$2.29M | −14.9%260.7K after |
Top 10 13F holders, Q2 2026
See all 379 holdersThe largest institutional positions in GRAIL, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 4,161,584 | $284.1M | 1.54% | +907,900+27.9% | Added |
| Baker Bros. Advisors LP | 4,028,614 | $275.0M | 1.38% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,577,075 | $244.2M | 0.00% | +608,539+20.5% | Added |
| State Street Corp | 2,385,514 | $162.9M | 0.00% | +493,621+26.1% | Added |
| Primecap Management Co | 2,180,106 | $148.8M | 0.09% | +336,334+18.2% | Added |
| Sessa Capital IM, L.P. | 2,037,518 | $139.1M | 2.41% | +318,204+18.5% | Added |
| Deep Track Capital, LP | 1,834,944 | $125.3M | 1.85% | +112,147+6.5% | Added |
| Vanguard Capital Management LLC | 1,641,117 | $112.0M | 0.00% | +114,012+7.5% | Added |
| Morgan Stanley | 1,462,163 | $99.8M | 0.01% | −170,032−10.4% | Reduced |
| Arbiter Partners Capital Management LLC | 1,034,297 | $70.6M | 37.73% | −3000.0% | Reduced |
Holders of 5% or more of GRAL
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of GRAIL, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13G/A | 9.80%4.03M shares | +4.50 ppfrom 5.30% | Feb 17, 20262 filings | May 15, 2026 | SEC |
| Farallon Capital Management, L.L.C. | 13G/A | 9.60%4.16M shares | – | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 7.90%3.38M shares | +1.40 ppfrom 6.50% | Jul 17, 20252 filings | Jul 28, 2026 | SEC |
| Farallon Capital Partners, L.P. | 13G/A | 7.80%3.25M shares | +1.90 ppfrom 5.90% | Nov 13, 20254 filings | May 11, 2026 | SEC |
| CRCM LP | 13G/A | 5.00%1.80M shares | −0.11 ppfrom 5.11% | Aug 30, 20245 filings | Oct 6, 2025 | SEC |